StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
Huagongshe Open Project:[email protected]KI-Anbindung: llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.7.8
Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 175671713Erstellt: 1. November 2026

Iodine-129

IODINE-129 · Iodine, isotope of mass 129, at.

https://huagongshe.com/de/chemical/175671713

Molekülstruktur von Iodine-129

Identifikatoren & physikalische Daten

CAS No.15046-84-1
SummenformelI
Durchschnittliche Molmasse128,905 g/mol
Monoisotopische Masse128,90498 g/mol
SMILES[129I]
InChIKeyZCYVEMRRCGMTRW-NJFSPNSNSA-N
PubChem CID175671713
DTXSIDDTXSID10933951

Chemische & physikalische Eigenschaften

XLogP0,9
Polarare Oberfläche (TPSA)0
H-Brücken-Donoren0
H-Brücken-Akzeptoren0
Frei drehbare Bindungen0
Schwere Atome1
Formalladung0
Komplexität0
EPA chemische InformationenIodine-129 (15046-84-1)

Sicherheit & Vorschriften

DOT Hazard ClassificationIodine-129Radioactive materialAtomic number: 53
TreatmentSodium thiosulphate, 100 mL orally of a 1% solution, has been recommended as an antidote because it immediately reduces iodine to iodide. Treatment reversing the effects of irradiation is currently not possible. Anaesthetics and antiemetics are administered to counter the symptoms of exposure, as well as antibiotics for countering secondary infections due to the resulting immune system deficiency. (L1852, L1848)
Gesundheitliche AuswirkungenExposure to high levels of nonradioactive and radioactive iodine can damage the thyroid. Damage to the thyroid gland can result in effects in other parts of your body, such as your skin, lung, and reproductive organs. Concentrated iodine is very corrosive and can damage the mucous membrane if swallowed. Radioactive iodine can also cause cancer, especially of the thyroid, where it tends to concentrate. (L1844, L1846, L1848)
ExpositionspfadeOral (L1844)Inhalation (L1844)dermal (L1844)
ToxizitätsübersichtIodide inhibits adenylate cyclase in thyroid gland follicle cells and decreases the TSH-induced rise in intracellular cAMP. This results in decreased iodination of thyroglobulin and inhibited production and release of T4 and T3, causing hypothyroidism. The ionizing radiation produced by radioiodine causes cellular damage that includes DNA breakage, accurate or inaccurate repair, apoptosis, gene mutations, chromosomal change, and genetic instability. This leads to loss of normal cell and tissue homeostasis, and development of malignancy. Ionizing radiation that does not directly damage DNA can produce reactive oxygen intermediates that directly affect the stability of p53, an important enzyme in cell-cycle regulation, and produce oxidative damage to individual bases in DNA and point mutations by mispairing during DNA replication. (L1837, L1841, L1844)
Signs and SymptomsIngestion of iodine may cause corrosive effects such as oedema of the glottis, with asphyxia, aspiration pneumonia, pulmonary oedema and shock, as well as vomiting and bloody diarrhea. The CNS, cardiovascular and renal toxicity following acute iodine ingestion appear to be due to the corrosive gastroenteritis and resultant shock. Vomiting, hypotension and circulatory collapse may be noted following severe intoxication. Exposure to high doses of ionizing radiation results in acute radiation syndrome, which can cause skin burns, hair loss, nausea, vomiting, dizziness, disorientation, low blood pressure, headache, fatigue, weakness, fever, birth defects, illness, infection, and death. (L1837, L1852, L1848)
Carcinogen ClassificationInternalized radionuclides that emit β particles are carcinogenic to humans (Group 1). γ-radiation is carcinogenic to humans (Group 1). (L2150) I-129 decays with low-energy beta and gamma emissions.